54 Biggest Movers From Yesterday
Gainers
Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 66.7% to close at $4.60 on Tuesday. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.
Novavax Stock Climbs Back Into Pattern On Vaccine News
Novavax Inc. (NASDAQ: NVAX) shares were trading higher Tuesday after the head of Vaccines Task Force for the European Medicines Agency reportedly said the company's COVID-19 vaccine could soon receive authorization in Europe.
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
A British study evaluating mixing COVID-19 vaccines showed a better immune response in people after the first dose of AstraZeneca
36 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Siyata Mobile Inc. (NASDAQ: SYTA) shares climbed 123.2% to $6.16. Siyata Mobile received $1.3 million purchase order for SD7 ruggedized devices and accessories.
Why Novavax Shares Are Surging Today
Novavax Inc (NASDAQ: NVAX) is trading significantly higher Tuesday after the head of the Vaccines Task Force for the European Medicines Agency reportedly said the company's COVID-19 vaccine could soon receive authorization in Europe.
What Are Whales Doing With Novavax
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Novavax Shares Jump After Head Of EU Drug Regulator Hints At Imminent Authorization For COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) shares are advancing Tuesday amid signals that the company's long-delayed COVID-19 vaccine could soon receive authorization in Europe.
Why Novavax Shares Are Falling
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 12.7% at $140.07 as vaccine names pull back after gaining in late November amid omicron concerns.
CNN Reporter Tweets ‘Good news on Omicron and vaccines: “The early indication is that you are going to be protected against serious illness with two doses of mRNA-containing vaccines. And the booster dose can increase antibodies,”‘
https://twitter.com/jimsciutto/status/1467928970092068864
Jim Cramer Shares His Thoughts On Novavax, ViacomCBS And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Seres Therapeutics, Inc. (NASDAQ: MCRB) is "too speculative" for an older person, as the company is not making any money. However, he recommended buying the stock in case you are young.